InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Selecky Christobel, Director. Insider active across 1 company, notably ImmunityBio, Inc.. In total, 5 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €1.3m. History available since 16 January 2026. The latest transaction was filed on 1 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Selecky Christobel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
35,064 shares@ US$2.980.0011% mcap4.4% of flowCommon StockSEC:0001849739-26-000014:0
124,414 shares@ US$2.990.0038% mcap15.8% of flowCommon StockSEC:0001849739-26-000014:1
159,478 shares@ US$9.02360.015% mcap61.2% of flowCommon StockSEC:0001849739-26-000014:2
25,000 shares@ US$2.980.0008% mcap16.5% of flowCommon StockSEC:0001849739-26-000004:0
50,000 shares@ US$2.980.0015% mcap33.5% of flowCommon StockSEC:0001849739-26-000002:0
5 of 5 declarations
About Selecky Christobel
Christobel Selecky serves as a Director at ImmunityBio, Inc. She contributes to strategic decision-making and oversight of the company's activities. Christobel brings valuable expertise in biotechnology and product development, contributing to the company's leadership. Her commitment to innovation is an asset to ImmunityBio.
